Loading stock data…
$162.46-0.77 (-0.48%)
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
ICU Medical, Inc. in the Healthcare sector is trading at $162.46 with a market capitalization of $4.1B. Wall Street consensus targets $193.38 (8 analysts), implying a +19.0% move over the next 12 months. The stock is currently 16% below its 52-week high of $192.85, remaining 10.1% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $551.68M↑ | $530.23M↓ | $540.70M↑ | $536.99M↓ | $548.87M |
| Gross Profit | $235.05M↑ | $206.23M↑ | $202.99M↑ | $200.88M↓ | $208.06M |
| Operating Income | $60.43M↑ | $30.38M↑ | $26.09M↓ | $26.86M↑ | $26.80M |
| Net Income | $19.09M↓ | $30.13M↑ | -$15.73M↓ | -$3.40M↓ | $35.34M |
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroCla...